Cargando…

Treatment of Cardiovascular Dysfunction With PDE5-Inhibitors – Temperature Dependent Effects on Transport and Metabolism of cAMP and cGMP

INTRODUCTION: Cardiovascular dysfunction is a potentially lethal complication of hypothermia. Due to a knowledge gap, pharmacological interventions are not recommended at core temperatures below 30°C. Yet, further cooling is induced in surgical procedures and survival of accidental hypothermia is re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Selli, Anders L., Kuzmiszyn, Adrina K., Smaglyukova, Natalia, Kondratiev, Timofei V., Fuskevåg, Ole-Martin, Lyså, Roy A., Ravna, Aina W., Tveita, Torkjel, Sager, Georg, Dietrichs, Erik S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361756/ https://www.ncbi.nlm.nih.gov/pubmed/34393818 http://dx.doi.org/10.3389/fphys.2021.695779

Ejemplares similares

Pharmacodynamic properties for inhibition of cAMP- and cGMP elimination by pentoxifylline remain unaltered in vitro during hypothermia
por: Selli, Anders Lund, et al.
Publicado: (2022)

Treatment of Cardiovascular Dysfunction with PDE3-Inhibitors in Moderate and Severe Hypothermia—Effects on Cellular Elimination of Cyclic Adenosine Monophosphate and Cyclic Guanosine Monophosphate
por: Kuzmiszyn, Adrina Kalasho, et al.
Publicado: (2022)

Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux
por: Subbotina, Anna, et al.
Publicado: (2017)

Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes
por: Pavlaki, Nikoleta, et al.
Publicado: (2018)

Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases
por: Sadek, Mirna S., et al.
Publicado: (2020)

PDE5 says NO to cGMP
por: LeBrasseur, Nicole
Publicado: (2003)

The NO/cGMP pathway inhibits transient cAMP signals through the activation of PDE2 in striatal neurons
por: Polito, Marina, et al.
Publicado: (2013)

Modulation of cGMP/cAMP crosstalk on the level of PDE3 in animals lacking NO-sensitive guanylyl cyclase
por: Friebe, Andreas, et al.
Publicado: (2015)

Identification of novel target proteins of cGMP/cAMP signaling pathway using cGMP/cAMP capture compound mass spectrometry (CCMS)
por: Luo, Yan, et al.
Publicado: (2009)

Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling
por: Mullershausen, Florian, et al.
Publicado: (2003)

Differential regulation of Paramecium ciliary motility by cAMP and cGMP
Publicado: (1988)

Biophysical Techniques for Detection of cAMP and cGMP in Living Cells
por: Sprenger, Julia U., et al.
Publicado: (2013)

CNP-pGC-cGMP-PDE3-cAMP Signal Pathway Upregulated in Gastric Smooth Muscle of Diabetic Rats
por: Cai, Ying-Lan, et al.
Publicado: (2015)

PDE3 is the major cGMP-PDE in adult mouse ventricular cardiomyocytes
por: Götz, Konrad R, et al.
Publicado: (2013)

IL-4 induces cAMP and cGMP in human monocytic cells
por: Dugas, B., et al.
Publicado: (1995)

Role of cGMP and cAMP in the hemodynamic response to intrathecal sildenafil administration
por: Bombarda, Gabriela, et al.
Publicado: (2011)

cGMP and cAMP differentially regulate differentiation and function of brown adipocytes
por: Jennissen, Katja, et al.
Publicado: (2011)

cGMP kinase I, cardiac hypertrophy and PDE inhibition
por: Patrucco, Enrico, et al.
Publicado: (2011)

PDE2, a component of the NO/cGMP signalling in the hippocampus
por: Schönle, Isabel, et al.
Publicado: (2011)

It takes two to tango: cardiac fibroblast-derived NO-induced cGMP enters cardiac myocytes and increases cAMP by inhibiting PDE3
por: Menges, Lukas, et al.
Publicado: (2023)

Comparison Between Two Pharmacologic Strategies to Alleviate Rewarming Shock: Vasodilation vs. Inodilation
por: Håheim, Brage, et al.
Publicado: (2020)

Excitation, adaption, and deadaptation of the cAMP-mediated cGMP Response in dictyostelium discoideum
por: Van Haaster, PJM, et al.
Publicado: (1983)

Differential regulation of platelet inhibition by cGMP- and cAMP-dependent protein kinases
por: Subramanian, Hariharan, et al.
Publicado: (2013)

Intermingled cAMP, cGMP and calcium spatiotemporal dynamics in developing neuronal circuits
por: Averaimo, Stefania, et al.
Publicado: (2014)

Plasticity and therapeutic potential of cAMP and cGMP-specific phosphodiesterases in Toxoplasma gondii
por: Vo, Kim Chi, et al.
Publicado: (2022)

CLEC‐2‐dependent activation of mouse platelets is weakly inhibited by cAMP but not by cGMP
por: Borgognone, A., et al.
Publicado: (2014)

Quantification of cAMP and cGMP analogs in intact cells: pitfalls in enzyme immunoassays for cyclic nucleotides
por: Werner, Katharina, et al.
Publicado: (2011)

Quantification of cAMP and cGMP analogs in intact cells: pitfals in enzyme immunoassays for cyclic nucleotides
por: Werner, Katharina, et al.
Publicado: (2011)

Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II
por: Mokni, Walid, et al.
Publicado: (2010)

Effects of thoracic epidural analgesia on plasma cAMP and cGMP levels in patients with heart failure
por: Li, Qing-Shu, et al.
Publicado: (2013)

Phosphodiesterases and Compartmentation of cAMP and cGMP Signaling in Regulation of Cardiac Contractility in Normal and Failing Hearts
por: Calamera, Gaia, et al.
Publicado: (2022)

Rhodopsin-cyclases for photocontrol of cGMP/cAMP and 2.3 Å structure of the adenylyl cyclase domain
por: Scheib, Ulrike, et al.
Publicado: (2018)

Upregulation of Phosphodiesterase 2A Augments T Cell Activation by Changing cGMP/cAMP Cross-Talk
por: Kurelic, Roberta, et al.
Publicado: (2021)

Structural Basis of Dual Specificity of Sinorhizobium meliloti Clr, a cAMP and cGMP Receptor Protein
por: Werel, Laura, et al.
Publicado: (2023)

Altered pharmacological effects of adrenergic agonists during hypothermia
por: Dietrichs, Erik Sveberg, et al.
Publicado: (2016)

CXCL12 targets the primary cilium cAMP/cGMP ratio to regulate cell polarity during migration
por: Atkins, Melody, et al.
Publicado: (2023)

Role of Ser102 and Ser104 as Regulators of cGMP Hydrolysis by PDE5A
por: Carøe Nordgaard, Julie, et al.
Publicado: (2014)

Asymmetric properties of rod cGMP Phosphodiesterase 6 (PDE6): structural and functional analysis
por: Qureshi, Bilal M, et al.
Publicado: (2015)

β(3)-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes
por: Schobesberger, Sophie, et al.
Publicado: (2020)

The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders
por: Degjoni, Anisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6tkmjjmi7j04datvub2ng0nbif